7.57
price down icon2.07%   -0.16
after-market After Hours: 7.50 -0.07 -0.92%
loading
Bioage Labs Inc stock is traded at $7.57, with a volume of 278.09K. It is down -2.07% in the last 24 hours and up +28.74% over the past month. Bioage Labs Inc is a clinical-stage biopharmaceutical company developing therapeutic product candidates for metabolic diseases, such as obesity, by targeting the biology of human aging. Its focus is metabolic disease, one of the greatest healthcare challenges. The pipeline Products of the company are NLRP3 inhibitors, APJ against, and others.
See More
Previous Close:
$7.73
Open:
$7.8
24h Volume:
278.09K
Relative Volume:
1.00
Market Cap:
$271.38M
Revenue:
-
Net Income/Loss:
-
P/E Ratio:
-
EPS:
-
Net Cash Flow:
-
1W Performance:
-0.39%
1M Performance:
+28.74%
6M Performance:
+80.24%
1Y Performance:
-67.92%
1-Day Range:
Value
$7.52
$7.87
1-Week Range:
Value
$7.245
$8.15
52-Week Range:
Value
$2.88
$24.00

Bioage Labs Inc Stock (BIOA) Company Profile

Name
Name
Bioage Labs Inc
Name
Phone
510-806-1445
Name
Address
5885 HOLLIS STREET, EMERYVILLE
Name
Employee
64
Name
Twitter
Name
Next Earnings Date
Name
Latest SEC Filings
Name
BIOA's Discussions on Twitter

Compare BIOA with other stocks

Stocks Price Market Cap Revenue Net Income Cash Flow EPS
Drug Manufacturers - Specialty & Generic icon
BIOA
Bioage Labs Inc
7.57 277.12M 0 0 0 0.00
Drug Manufacturers - Specialty & Generic icon
ZTS
Zoetis Inc
144.09 63.86B 9.39B 2.62B 2.22B 5.8121
Drug Manufacturers - Specialty & Generic icon
TAK
Takeda Pharmaceutical Co Adr
13.44 41.80B 29.96B 957.25M 4.77B 0.2956
Drug Manufacturers - Specialty & Generic icon
HLN
Haleon Plc Adr
9.27 40.88B 14.26B 1.98B 2.47B 0.4327
Drug Manufacturers - Specialty & Generic icon
TEVA
Teva Pharmaceutical Industries Ltd Adr
20.48 22.98B 16.70B -157.13M 1.19B -0.1446
Drug Manufacturers - Specialty & Generic icon
UTHR
United Therapeutics Corp
445.43 19.53B 3.08B 1.24B 1.07B 25.61

Bioage Labs Inc Stock (BIOA) Upgrades & Downgrades

Date Action Analyst Rating Change
Oct-22-25 Upgrade Citigroup Neutral → Buy
Feb-28-25 Initiated William Blair Mkt Perform
Dec-10-24 Downgrade Morgan Stanley Overweight → Underweight
Dec-09-24 Downgrade Citigroup Buy → Neutral
Dec-09-24 Downgrade Jefferies Buy → Hold
Oct-21-24 Initiated Citigroup Buy
Oct-21-24 Initiated Jefferies Buy
Oct-21-24 Initiated Morgan Stanley Overweight
View All

Bioage Labs Inc Stock (BIOA) Latest News

pulisher
04:55 AM

Obesity Drugmaker Escapes Clinical Trial Securities Suit - Law360

04:55 AM
pulisher
12:34 PM

BioAge Labs (NASDAQ:BIOA) Given Sell (D-) Rating at Weiss Ratings - MarketBeat

12:34 PM
pulisher
11:04 AM

BioAge Beats IPO Investor Lawsuit Over Weight Loss Trial End - Bloomberg Law News

11:04 AM
pulisher
09:31 AM

Why BioAge Labs Inc. (Y7G) stock stays undervaluedMarket Volume Report & Free High Accuracy Swing Entry Alerts - newser.com

09:31 AM
pulisher
06:52 AM

Does BioAge Labs Inc. show high probability of reboundJuly 2025 Decliners & Expert Approved Momentum Trade Ideas - newser.com

06:52 AM
pulisher
06:01 AM

Sector ETF performance correlation with BioAge Labs Inc.Earnings Overview Report & Risk Controlled Daily Trade Plans - newser.com

06:01 AM
pulisher
05:39 AM

How BioAge Labs Inc. stock compares to growth peers2025 Major Catalysts & AI Powered Buy/Sell Recommendations - newser.com

05:39 AM
pulisher
05:36 AM

Automated trading signals detected on BioAge Labs Inc.July 2025 Fed Impact & High Accuracy Investment Signals - newser.com

05:36 AM
pulisher
04:44 AM

Analyzing drawdowns of BioAge Labs Inc. with statistical toolsJuly 2025 Decliners & Expert Approved Momentum Trade Ideas - newser.com

04:44 AM
pulisher
02:39 AM

Can BioAge Labs Inc. stock resist sector downturnsQuarterly Profit Report & Comprehensive Market Scan Insights - newser.com

02:39 AM
pulisher
01:32 AM

Order flow analysis tools used on BioAge Labs Inc.CEO Change & Weekly Market Pulse Updates - newser.com

01:32 AM
pulisher
12:35 PM

Published on: 2025-10-30 23:35:20 - newser.com

12:35 PM
pulisher
12:24 PM

Using data models to predict BioAge Labs Inc. stock movementBuy Signal & Weekly Stock Performance Updates - newser.com

12:24 PM
pulisher
Oct 30, 2025

BioAge Labs, Inc. (NASDAQ:BIOA) Short Interest Update - MarketBeat

Oct 30, 2025
pulisher
Oct 30, 2025

Why BioAge Labs Inc. stock could be next big winnerBull Run & Verified Stock Trade Ideas - newser.com

Oct 30, 2025
pulisher
Oct 30, 2025

What candlestick patterns are forming on BioAge Labs Inc.Market Weekly Review & AI Driven Price Predictions - newser.com

Oct 30, 2025
pulisher
Oct 30, 2025

Is BioAge Labs Inc. stock attractive for long term wealth building2025 Trading Volume Trends & Growth-Oriented Investment Plans - newser.com

Oct 30, 2025
pulisher
Oct 29, 2025

Citigroup Maintains BioAge Labs (BIOA) Buy Recommendation - Nasdaq

Oct 29, 2025
pulisher
Oct 29, 2025

Bioage Labs (BIOA) Receives Raised Price Target from Citigroup | - GuruFocus

Oct 29, 2025
pulisher
Oct 29, 2025

Could This Anti-Obesity Drug Biotech Be Poised to Soar in 2026? - AOL.com

Oct 29, 2025
pulisher
Oct 29, 2025

Is BioAge Labs Inc. (Y7G) stock supported by free cash flow2025 Historical Comparison & Expert Verified Stock Movement Alerts - newser.com

Oct 29, 2025
pulisher
Oct 29, 2025

Analyzing BioAge Labs Inc. with risk reward ratio chartsWeekly Profit Report & Fast Moving Stock Watchlists - newser.com

Oct 29, 2025
pulisher
Oct 28, 2025

BioAge Labs (BIOA) Price Target Increased by 71.43% to 8.16 - Nasdaq

Oct 28, 2025
pulisher
Oct 28, 2025

Positive Week for BioAge Labs, Inc. (NASDAQ:BIOA) Institutional Investors Who Lost 68% Over the Past Year - 富途牛牛

Oct 28, 2025
pulisher
Oct 28, 2025

How strong is BioAge Labs Inc. (Y7G) stock earnings growthJuly 2025 Technicals & Technical Pattern Alert System - newser.com

Oct 28, 2025
pulisher
Oct 28, 2025

Will BioAge Labs Inc. stock benefit from infrastructure spendingJuly 2025 Snapshot & Weekly Setup with High ROI Potential - Fundação Cultural do Pará

Oct 28, 2025
pulisher
Oct 27, 2025

Published on: 2025-10-27 22:26:35 - newser.com

Oct 27, 2025
pulisher
Oct 27, 2025

How to Value Scintilla Commercial Credit Limited Stock Using DCF AnalysisRSI Overbought/Oversold & Low Entry Investment Ideas - earlytimes.in

Oct 27, 2025
pulisher
Oct 27, 2025

Is BioAge Labs Inc a good long term investmentSwing Trading Watchlist & Free Grow Wealth With Picks - earlytimes.in

Oct 27, 2025

Bioage Labs Inc Stock (BIOA) Financials Data

There is no financial data for Bioage Labs Inc (BIOA). Check out other stocks for more information.

Revenue

loading

Net Income

loading

Cash Flow

loading

EPS

loading
$45.46
price up icon 3.18%
$22.15
price down icon 1.86%
drug_manufacturers_specialty_generic RDY
$13.29
price down icon 1.19%
$10.36
price up icon 0.00%
$143.21
price up icon 3.75%
$445.43
price down icon 1.79%
Cap:     |  Volume (24h):